Research Support, if applicable:
(Specify types and grant/award numbers)
NIH Intramural Research:
NIH Extramural Research:
Other Federal Funding:
State Funding:
Private Foundation:
Funding Outside of United States:
Industry:
Other:
Certification of Use
The MATERIAL ("tetramers, monomers and other novel ligands provided by the tetramer facility") and its
use is claimed in U.S. Patent 5,635,363 and corresponding foreign patents relating to "Detection,
Enumeration, Purification of Antigen-Specific T Cells." The rights to these patents are assigned to Stanford
University and licensed exclusively to Beckman Coulter, Inc. (BCI). Stanford has granted the US
Government a nonexclusive license under 35 U.S.C. § 202 (c)(4). BCI has granted NIH the right to provide
the Recipient with a sublicense, and NIH hereby grants Recipient a sublicense to use the Material under the
following conditions.
Requester's Institution acting through its investigator ("Recipient") agrees that, when the US Government is
providing financial support to the Recipient for a research or clinical development activity in which the
Material will be used, the Recipient Institution will use the materials provided by the NIH Tetramer Facility
in activities only within the scope of the US Government funding agreement.
Recipient agrees that, when the US Government is not providing any financial support to the Recipient
Institution for a research or clinical development activity in which the Material will be used, the Recipient
will use the Material for its internal noncommercial research purposes only. The Material will not be used
for any commercial purpose, for use in man, or for the direct benefit of any for-profit institution.
Accordingly and without limitation, the Recipient is not permitted under this Material Transfer Agreement
to use any Material to test compounds for any commercial purpose, for use in man, or for the direct benefit
of any for-profit institution or use the Materials for the production of products for any commercial purpose
or for the direct benefit of any for-profit institution. For purposes of this agreement, the term "commercial
purposes" shall be broadly construed to mean any purpose wherein consideration, in any form, is received.
Page 3